Free Trial

Henry Schein (HSIC) Stock Forecast & Price Target

Henry Schein logo
$70.97 +0.96 (+1.37%)
(As of 12/26/2024 05:22 PM ET)

Henry Schein - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
6
Buy
5

Based on 11 Wall Street analysts who have issued ratings for Henry Schein in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 11 analysts, 6 have given a hold rating, 4 have given a buy rating, and 1 has given a strong buy rating for HSIC.

Consensus Price Target

$78.89
11.16% Upside
According to the 11 analysts' twelve-month price targets for Henry Schein, the average price target is $78.89. The highest price target for HSIC is $86.00, while the lowest price target for HSIC is $72.00. The average price target represents a forecasted upside of 11.16% from the current price of $70.97.
Get the Latest News and Ratings for HSIC and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Henry Schein and its competitors.

Sign Up

HSIC Analyst Ratings Over Time

TypeCurrent Forecast
12/28/23 to 12/27/24
1 Month Ago
11/28/23 to 11/27/24
3 Months Ago
9/29/23 to 9/28/24
1 Year Ago
12/28/22 to 12/28/23
Strong Buy
1 Strong Buy rating(s)
1 Strong Buy rating(s)
1 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
4 Buy rating(s)
5 Buy rating(s)
5 Buy rating(s)
5 Buy rating(s)
Hold
6 Hold rating(s)
5 Hold rating(s)
5 Hold rating(s)
1 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$78.89$78.89$77.10$79.25
Forecasted Upside11.16% Upside1.58% Upside5.30% Upside4.19% Upside
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy

HSIC Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

HSIC Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Henry Schein Stock vs. The Competition

TypeHenry ScheinMedical CompaniesS&P 500
Consensus Rating Score
2.55
2.81
2.51
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside11.16% Upside25,769.18% Upside13.32% Upside
News Sentiment Rating
Neutral News

See Recent HSIC News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
12/4/2024Mizuho
3 of 5 stars
S. Valiquette
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageNeutral$75.00-0.28%
11/6/2024Barrington Research
4 of 5 stars
 Reiterated RatingOutperform ➝ Outperform$82.00 ➝ $82.00+17.43%
10/8/2024Evercore ISI
2 of 5 stars
 Boost TargetIn-Line ➝ In-Line$70.00 ➝ $74.00+5.99%
8/12/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight ➝ Overweight$88.00 ➝ $80.00+17.20%
8/7/2024UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral ➝ Neutral$75.00 ➝ $72.00+7.29%
8/7/2024Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform ➝ Outperform$92.00 ➝ $82.00+21.68%
7/22/2024Baird R W
Subscribe to MarketBeat All Access for the recommendation accuracy rating
J. Johnson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Strong-Buy
6/21/2024Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOverweight ➝ Overweight$86.00 ➝ $86.00+27.37%
3/6/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetHold ➝ Hold$74.00 ➝ $81.00+7.41%
2/26/2024Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
M. Cherny
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Perform
2/26/2024Leerink Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageMarket Perform$78.00-2.33%
11/27/2023Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy$75.00+9.91%
11/14/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetUnderweight ➝ Underweight$69.00 ➝ $65.00-3.90%
8/8/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform ➝ Outperform$96.00+26.53%
8/7/2023Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$76.00 ➝ $75.00-1.15%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 04:52 AM ET.


HSIC Forecast - Frequently Asked Questions

According to the research reports of 11 Wall Street equities research analysts, the average twelve-month stock price forecast for Henry Schein is $78.89, with a high forecast of $86.00 and a low forecast of $72.00.

11 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Henry Schein in the last year. There are currently 6 hold ratings, 4 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" HSIC shares.

According to analysts, Henry Schein's stock has a predicted upside of 11.16% based on their 12-month stock forecasts.

Henry Schein has been rated by research analysts at Barrington Research, Evercore ISI, and Mizuho in the past 90 days.

Analysts like Henry Schein less than other "medical" companies. The consensus rating score for Henry Schein is 2.55 while the average consensus rating score for "medical" companies is 2.81. Learn more on how HSIC compares to other companies.


This page (NASDAQ:HSIC) was last updated on 12/27/2024 by MarketBeat.com Staff
From Our Partners